Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations.
Lou NN, Zhang XC, Chen HJ, Zhou Q, Yan LX, Xie Z, Su J, Chen ZH, Tu HY, Yan HH, Wang Z, Xu CR, Jiang BY, Wang BC, Bai XY, Zhong WZ, Wu YL, Yang JJ.
Lou NN, et al. Among authors: jiang by.
Oncotarget. 2016 Oct 4;7(40):65185-65195. doi: 10.18632/oncotarget.11218.
Oncotarget. 2016.
PMID: 27533086
Free PMC article.